People

Hania A. Al-Hallaq, PhD

Dr. Hania Al-Hallaq is an Associate Professor at the University of Chicago in the Department of Radiation & Cellular Oncology. She received her Ph.D. from the University of Chicago Medical Physics program in 1994 after studying the oxygenation status of tumors using BOLD MRI in Greg Karczmar’s laboratory. Hania was also the first resident in Therapeutic Physics at The University of Chicago graduating in 2002.



After a couple of years as a clinical physicist at a large hospital system in the Chicago suburbs, she returned as faculty in Radiation Oncology at the University of Chicago in 2004. She is currently Associate Director of the Graduate Program in Medical Physics and Director of the Medical Physics Certificate Program. Her research focuses on the use of medical imaging to guide treatment positioning and assess treatment response following radiotherapy. She has developed expertise in both x-ray and 3D surface imaging modalities for breast cancer treatments and is chair of TG-302: Surface image-guided radiotherapy. She has published on the use of CT radiomics to predict which patients might later develop RT-induced pneumonitis.



Currently, she serves as Physics PI for several national protocols studying the safety and efficacy of SBRT for metastatic disease (NRG-BR001, NRG-BR002, ALLIANCE-A091505). She is an associate physics editor for the International Journal of Radiation Oncology, Biology, Physics.

American Board of Radiology
Tuscon, AZ
- Therapeutic Physics Certification
06/2003

The University of Chicago
Chicago, IL
- Therapeutic Physics Residency
08/2002

The University of Chicago
Chicago, IL
Ph.D. - Medical Physics
08/2000

Bryn Mawr College
Bryn Mawr, PA
A.B. - Physics
05/1994

Dosimetric quality endpoints for low-dose-rate prostate brachytherapy using biological effective dose (BED) vs. conventional dose.
Singh R, Al-Hallaq H, Pelizzari CA, Zagaja GP, Chen A, Jani AB. Dosimetric quality endpoints for low-dose-rate prostate brachytherapy using biological effective dose (BED) vs. conventional dose. Med Dosim. 2003; 28(4):255-9.
PMID: 14684190

Safety and Clinical Activity of Pembrolizumab and Multisite Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors.
Luke JJ, Lemons JM, Karrison TG, Pitroda SP, Melotek JM, Zha Y, Al-Hallaq HA, Arina A, Khodarev NN, Janisch L, Chang P, Patel JD, Fleming GF, Moroney J, Sharma MR, White JR, Ratain MJ, Gajewski TF, Weichselbaum RR, Chmura SJ. Safety and Clinical Activity of Pembrolizumab and Multisite Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors. J Clin Oncol. 2018 06 01; 36(16):1611-1618.
PMID: 29437535

Comparison of Two Deformable Registration Algorithms in the Presence of Radiologic Change Between Serial Lung CT Scans.
Cunliffe AR, White B, Justusson J, Straus C, Malik R, Al-Hallaq HA, Armato SG. Comparison of Two Deformable Registration Algorithms in the Presence of Radiologic Change Between Serial Lung CT Scans. J Digit Imaging. 2015 Dec; 28(6):755-60.
PMID: 25822396

Lung texture in serial thoracic CT scans: correlation with radiologist-defined severity of acute changes following radiation therapy.
Cunliffe AR, Armato SG, Straus C, Malik R, Al-Hallaq HA. Lung texture in serial thoracic CT scans: correlation with radiologist-defined severity of acute changes following radiation therapy. Phys Med Biol. 2014 Sep 21; 59(18):5387-98.
PMID: 25157625

Lung texture in serial thoracic CT scans: assessment of change introduced by image registration.
Cunliffe AR, Al-Hallaq HA, Labby ZE, Pelizzari CA, Straus C, Sensakovic WF, Ludwig M, Armato SG. Lung texture in serial thoracic CT scans: assessment of change introduced by image registration. Med Phys. 2012 Aug; 39(8):4679-90.
PMID: 22894392

Initial experience using superflab as intravaginal packing during interstitial brachytherapy for advanced gynecologic cancer.
Kharouta M, Malin M, Son C, Al-Hallaq H, Hasan Y. Initial experience using superflab as intravaginal packing during interstitial brachytherapy for advanced gynecologic cancer. J Contemp Brachytherapy. 2018 Jun; 10(3):218-224.
PMID: 30038641

Using high spectral and spatial resolution bold MRI to choose the optimal oxygenating treatment for individual cancer patients.
al-Hallaq HA, Zamora MA, Fish BL, Halpern HJ, Moulder JE, Karczmar GS. Using high spectral and spatial resolution bold MRI to choose the optimal oxygenating treatment for individual cancer patients. Adv Exp Med Biol. 2003; 530:433-40.
PMID: 14562738

Functional and anatomic imaging of tumor vasculature: high-resolution MR spectroscopic imaging combined with a superparamagnetic contrast agent.
Karczmar GS, Fan X, Al-Hallaq H, River JN, Tarlo K, Kellar KE, Zamora M, Rinker-Schaeffer C, Lipton MJ. Functional and anatomic imaging of tumor vasculature: high-resolution MR spectroscopic imaging combined with a superparamagnetic contrast agent. Acad Radiol. 2002 May; 9 Suppl 1:S115-8.
PMID: 12019844

Uptake of a superparamagnetic contrast agent imaged by MR with high spectral and spatial resolution.
Karczmar GS, Fan X, Al-Hallaq HA, Zamora M, River JN, Rinker-Schaeffer C, Zaucha M, Tarlo K, Kellar K. Uptake of a superparamagnetic contrast agent imaged by MR with high spectral and spatial resolution. Magn Reson Med. 2000 May; 43(5):633-9.
PMID: 10800026

Variation in algorithm implementation across radiomics software.
Foy JJ, Robinson KR, Li H, Giger ML, Al-Hallaq H, Armato SG. Variation in algorithm implementation across radiomics software. J Med Imaging (Bellingham). 2018 Oct; 5(4):044505.
PMID: 30840747

View All Publications

NRG Oncology Outstanding Manuscript
NRG Oncology Clinical Trials
2017

Kurt Rossmann Award for Excellence in Medical Physics Graduate Teaching
The University of Chicago
2017

Franca Kuchnir Award for Excellence in Physics Residency Teaching
The University of Chicago
2009

Kurt Rossmann Award for Excellence in Medical Physics Graduate Teaching
The University of Chicago
2006